Wedbush Boosts Progress Software (NASDAQ:PRGS) Price Target to $67.00
Progress Software (NASDAQ:PRGS – Free Report) had its price target boosted by Wedbush from $65.00 to $67.00 in a research report report published on Friday,...
Revance Therapeutics (NASDAQ:RVNC) PT Lowered to $12.00 at HC Wainwright
Revance Therapeutics (NASDAQ:RVNC – Free Report) had its price objective lowered by HC Wainwright from $15.00 to $12.00 in a research report released on Friday,...
Stifel Nicolaus Trims Playtika (NASDAQ:PLTK) Target Price to $11.00
Playtika (NASDAQ:PLTK – Free Report) had its target price lowered by Stifel Nicolaus from $12.00 to $11.00 in a report released on Friday, Benzinga reports....
Option Care Health (NASDAQ:OPCH) Price Target Raised to $38.00
Option Care Health (NASDAQ:OPCH – Free Report) had its price target raised by Barrington Research from $35.00 to $38.00 in a research note published on...
Oppenheimer Reaffirms Outperform Rating for Universal Display (NASDAQ:OLED)
Oppenheimer restated their outperform rating on shares of Universal Display (NASDAQ:OLED – Free Report) in a research note released on Friday, Benzinga reports. The firm...
Canaccord Genuity Group Boosts Intellia Therapeutics (NASDAQ:NTLA) Price Target to $73.00
Intellia Therapeutics (NASDAQ:NTLA – Free Report) had its target price upped by Canaccord Genuity Group from $72.00 to $73.00 in a report released on Friday...